Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Neoplasms 8 cyclopia sequence 7 Prostatic Neoplasms 7 Polycystic Ovary Syndrome 5 Fatigue 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain 3 Obesity 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Leiomyoma 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neoplasms, Plasma Cell 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Insulin Resistance 2 Infertility 2 Hyperandrogenism 2 Hematologic Diseases 2 Depression 2 Burkitt Lymphoma 2 Weight Loss 1

Interventions

lithium sulfate 1 Surveys and Questionnaires 1 Sugars 1 Pioglitazone 1 Methods 1 Lithium 1 Interviews as Topic 1 Hematologic Tests 1 Echocardiography 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Memory Disorders × Sugars × Clear all

NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed

276 enrolled 33 charts

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡